NAFDAC grants provisional approval for malaria vaccine, aiming to reduce child mortality The provisional approval for R21/Matrix malaria vaccine by the National Agency for Food and Drug Administration And Control (NAFDAC), has raised hope in Nigeria as stakeholders in the health sector believe that the vaccine will drastically reduce child mortality in the country. NAFDAC, on Monday granted provisional approval for the vaccine days after Ghana became the first country to approve the vaccine, which is manufactured by the Serum Institute of India Pvt Ltd. Director-General of NAFDAC, Prof. Mojisola Adeyeye, who...